Sitaxentan sodium (TBC-11251) is a medication for the treatment of pulmonary arterial hypertension (PAH).[1] It was marketed as Thelin by Encysive Pharmaceuticals until Pfizer purchased Encysive in February 2008. In 2010, Pfizer voluntarily removed sitaxentan from the market due to concerns about liver toxicity.[2]
^Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, et al. (February 2004). "Sitaxsentan therapy for pulmonary arterial hypertension". American Journal of Respiratory and Critical Care Medicine. 169 (4): 441–447. doi:10.1164/rccm.200307-957OC. PMID 14630619.
Sitaxentan sodium (TBC-11251) is a medication for the treatment of pulmonary arterial hypertension (PAH). It was marketed as Thelin by Encysive Pharmaceuticals...
Three main kinds of ERAs exist: selective ETA receptor antagonists (sitaxentan, ambrisentan, atrasentan, BQ-123, sparsentan, zibotentan, avosentan, edonentan...
failure. Two drugs, sitaxentan sodium (also spelled sitaxsentan) and TBC3711, were tested in clinical trials under the partnership. Sitaxentan was designed to...
Thelin may refer to: Sitaxentan, a medication Björn Thelin (1942–2017), a member of The Spotnicks Eje Thelin (1938–1990), a Swedish trombonist Howard J...
is another ETA and ETB dual endothelin receptor blocker that is used. Sitaxentan (Thelin) was approved for use in Canada, Australia, and the European Union...
Kingdom, and the United States Increased risk of heart attack and stroke. Sitaxentan 2010 Germany Hepatotoxicity. Sorivudine 1993 Japan Drug interaction and...
antagonist selective for subtype A (ETA). While other drugs of this type (sitaxentan, ambrisentan) exploit the vasoconstrictive properties of endothelin and...
hypertension, which was treatable in preliminary research by bosentan, sitaxentan or ambrisentan. Endothelins have involvement in cardiovascular function...